Figure 7.
Figure 7. A role for CD9 in the formation of antigen-dependent monocyte/T-cell conjugates. CMFDA-labeled monocytes loaded or not with SEE were incubated for various periods of time with CMTMR-labeled Jurkat cells before flow cytometry. (A) Conjugate formation at t = 0 minute and t = 40 minutes of incubation between monocytes loaded with 10 μg/mL of SEE and Jurkat cells are detected as CMFDA+ CMTMR+ events. (B) Kinetic analysis of conjugate formation between CMFDA-labeled monocytes loaded or not with SEE (10 μg/mL) and CMTMR-labeled Jurkat cells. (C) CMFDA-labeled monocytes loaded or not with SEE (10 μg/mL) were incubated with CD9 (PHN200), CD38 (IB4), anti–HLA-DR (D1.12), CD11A (HI-111), or isotype control mAbs (5 μg/mL) before conjugate formation with Jurkat cells. The percent of SEE-specific conjugates are indicated for different times. (D) Formation of conjugates was analyzed for different concentrations of SEE and different concentrations of CD9 mAbs.

A role for CD9 in the formation of antigen-dependent monocyte/T-cell conjugates. CMFDA-labeled monocytes loaded or not with SEE were incubated for various periods of time with CMTMR-labeled Jurkat cells before flow cytometry. (A) Conjugate formation at t = 0 minute and t = 40 minutes of incubation between monocytes loaded with 10 μg/mL of SEE and Jurkat cells are detected as CMFDA+ CMTMR+ events. (B) Kinetic analysis of conjugate formation between CMFDA-labeled monocytes loaded or not with SEE (10 μg/mL) and CMTMR-labeled Jurkat cells. (C) CMFDA-labeled monocytes loaded or not with SEE (10 μg/mL) were incubated with CD9 (PHN200), CD38 (IB4), anti–HLA-DR (D1.12), CD11A (HI-111), or isotype control mAbs (5 μg/mL) before conjugate formation with Jurkat cells. The percent of SEE-specific conjugates are indicated for different times. (D) Formation of conjugates was analyzed for different concentrations of SEE and different concentrations of CD9 mAbs.

Close Modal

or Create an Account

Close Modal
Close Modal